More than 55 years of research into this molecule have placed Fidia at the forefront in the production of both natural and functionalized hyaluronic acid, using proprietary and validated manufacturing processes, with different ranges of molecular weight, according to the design characteristics of the finished products.

In addition, Fidia’s breakthrough patented technology process allows to chemically modify the molecule in order to obtain suitable derivatives, with different physical and biological properties to improve the quality of care and better meet an individual patient’s needs.

Fidia is continually working to identify new opportunities and holds an extensive patent portfolio worldwide – 1.100, of which over 700 involve hyaluronic acid with different molecular weights, industrial processes, formulations, compositions, derivatives and applications.

Hyaluronic acid

- Extraction from different sources
- In-house developed and patented methods
- Different molecular weights
- Specific physico-chemical characteristics

Farmaceutici S.p.A.

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.